CClinicalTrials.gg
CompletedNCT02577380Updated Aug 15, 2017

Addressing Gender Based Violence in HIV Testing and Counseling

An interventional study of IPV/GBV HTC in Intimate Partner Violence, sponsored by Population Council. Completed. Open to female participants aged 15 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-15.

Sponsored by Population Council · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
15 Years to 49 Years
Sex
Female
01

Study summary

The overarching goal of this study is to pilot an approach to HIV testing and counseling (HTC) that addresses intimate partner violence. The results of the study will fill an important gap in the literature and contribute to efforts by Kenyatta National Hospital in Nairobi, Kenya-and the HIV and sexual and reproductive health field globally-to better address intimate partner violence in our work.

02

Conditions studied

  • Intimate Partner Violence
03

In context

Lead sponsor

Population Council is the lead sponsor of 25 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Lived in the community for at least one year
  • Aged 15-49 years
  • Satisfy gender requirement

Exclusion criteria

Exclusion Criteria:

  • Lack of informed consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (actual)

Study arms

  • Experimental
    IPV/GBV HIV testing and counseling

    For the randomized controlled trial, first-time antenatal care clients will be randomly assigned to IPV/GBV HTC HIV testing.

    Behavioral: IPV/GBV HTC

  • No intervention
    Standard HIV testing and counseling

    For the randomized controlled trial, first-time antenatal care clients will be randomly assigned to Standard HIV testing and counseling.

Interventions

  • BehavioralIPV/GBV HTC

    Participants will be interviewed after receiving their services.

06

What researchers measure

Primary outcomes

  1. Comparison of HTC experiences

    Number of ANC clients who meet an expected result of a survey with the intervention group (IPV/GBV-HTC) or with the control group (standard HTC). The score is based on answers given to attitudes toward study participant knowledge regarding IPV/GBV; awareness of IPV/GBV services; and agency regarding talking with their partner about HIV testing.

    Time frame: 10 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Haberland N, Ndwiga C, McCarthy K, Pulerwitz J, Kosgei R, Mak'anyengo M, Peltz A, Wong VJ, Kalibala S. Addressing Intimate Partner Violence and Power in Intimate Relationships in HIV Testing Services in Nairobi, Kenya. AIDS Behav. 2020 Aug;24(8):2409-2420. doi: 10.1007/s10461-020-02801-9. PubMed 32026250 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02577380
Lead sponsor
Population Council
Collaborators
United States Agency for International Development (USAID)
Responsible party
Sponsor
First posted
Oct 16, 2015
Start date
Jun 2014
Primary completion
Sep 2015
Completion
Sep 2015
Last update
Aug 15, 2017

Study contacts

Nicole Haberland, MPH
principal investigator · Population Council

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion